Login / Signup

The effect of synbiotic adjunct therapy on clinical and paraclinical outcomes in hospitalized COVID-19 patients: A randomized placebo-controlled trial.

Mahsa VaeziSahar RavanshadMina Akbari RadHossein ZarrinfarMona Kabiri
Published in: Journal of medical virology (2023)
Our findings provide the support that synbiotic adjuvant therapy for two weeks can be effective to modulate inflammatory responses against COVID-19 infection. This article is protected by copyright. All rights reserved.
Keyphrases
  • sars cov
  • early stage
  • double blind
  • study protocol
  • type diabetes
  • randomized controlled trial
  • skeletal muscle
  • glycemic control
  • preterm birth